Oruka Therapeutics (ORKA) Capital Expenditures (2010 - 2026)
Oruka Therapeutics (ORKA) posted Capital Expenditures of $73,000 for Q1 2026, up 461.5% from $13,000 a year earlier and up 15.9% from the prior quarter.
Powered by 
Analysis
Oruka Therapeutics (ORKA) Capital Expenditures (2010 - 2026) Analysis & Trends
For FY2025, Oruka Therapeutics' Capital Expenditures came in at $209,000, up 10.6% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of 61.5% (FY2020 to FY2025).
- In prior years, Oruka Therapeutics' Capital Expenditures was $189,000 in FY2024, $2,000 in FY2022 (-95.3%) and $43,000 in FY2021 (+126.3%).
- Quarterly Capital Expenditures has run from a low of $2,000 in Q1 2022 to a high of $99,000 in Q3 2025 over five years.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $63,000 (Q4 2025), $99,000 (Q3 2025) and $34,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Oruka Therapeutics | 5.24 Bn | 3.29 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 73,000.00 |
| Dec 31, 2025 | 63,000.00 |
| Sep 30, 2025 | 99,000.00 |
| Jun 30, 2025 | 34,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Dec 31, 2024 | 18,000.00 |
| Mar 31, 2022 | 2,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 14,000.00 |
| Jun 30, 2021 | 16,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Dec 31, 2020 | 13,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Dec 31, 2019 | 2,000.00 |
| Sep 30, 2018 | 3,000.00 |
| Mar 31, 2018 | 1,000.00 |
| Dec 31, 2017 | 1,000.00 |
| Dec 31, 2016 | 4,000.00 |
| Sep 30, 2016 | 6,000.00 |
API Access
Oruka Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ORKA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ORKA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ORKA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();